234 related articles for article (PubMed ID: 31821039)
41. Acid sphingomyelinase downregulation alleviates vascular endothelial leptin resistance in rats.
Cai BB; Lu YN; Xu M
Acta Pharmacol Sin; 2020 May; 41(5):650-660. PubMed ID: 31848475
[TBL] [Abstract][Full Text] [Related]
42. Propionic acid and not caproic acid, attenuates nonalcoholic steatohepatitis and improves (cerebro) vascular functions in obese Ldlr
Tengeler AC; Gart E; Wiesmann M; Arnoldussen IAC; van Duyvenvoorde W; Hoogstad M; Dederen PJ; Verweij V; Geenen B; Kozicz T; Kleemann R; Morrison MC; Kiliaan AJ
FASEB J; 2020 Jul; 34(7):9575-9593. PubMed ID: 32472598
[TBL] [Abstract][Full Text] [Related]
43. Small-hairpin RNA and pharmacological targeting of neutral sphingomyelinase prevent diaphragm weakness in rats with heart failure and reduced ejection fraction.
Coblentz PD; Ahn B; Hayward LF; Yoo JK; Christou DD; Ferreira LF
Am J Physiol Lung Cell Mol Physiol; 2019 Apr; 316(4):L679-L690. PubMed ID: 30702345
[TBL] [Abstract][Full Text] [Related]
44. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.
Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J
J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005
[TBL] [Abstract][Full Text] [Related]
45. High Fat High Cholesterol Diet (Western Diet) Aggravates Atherosclerosis, Hyperglycemia and Renal Failure in Nephrectomized LDL Receptor Knockout Mice: Role of Intestine Derived Lipopolysaccharide.
Ghosh SS; Righi S; Krieg R; Kang L; Carl D; Wang J; Massey HD; Sica DA; Gehr TW; Ghosh S
PLoS One; 2015; 10(11):e0141109. PubMed ID: 26580567
[TBL] [Abstract][Full Text] [Related]
46. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG
Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005
[TBL] [Abstract][Full Text] [Related]
47. Diallyl disulfide attenuates non‑alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, lipid peroxidation and inflammation in mice.
Zhang N; Wang Y; Zhang J; Liu B; Li G; Xin S; Xu K
Mol Med Rep; 2019 Aug; 20(2):1363-1372. PubMed ID: 31173200
[TBL] [Abstract][Full Text] [Related]
48. Digoxin improves steatohepatitis with differential involvement of liver cell subsets in mice through inhibition of PKM2 transactivation.
Zhao P; Han SN; Arumugam S; Yousaf MN; Qin Y; Jiang JX; Torok NJ; Chen Y; Mankash MS; Liu J; Li J; Iwakiri Y; Ouyang X
Am J Physiol Gastrointest Liver Physiol; 2019 Oct; 317(4):G387-G397. PubMed ID: 31411894
[TBL] [Abstract][Full Text] [Related]
49. Acid Sphingomyelinase Down-regulation Alleviates Vascular Endothelial Insulin Resistance in Diabetic Rats.
Li X; Jin SJ; Su J; Li XX; Xu M
Basic Clin Pharmacol Toxicol; 2018 Dec; 123(6):645-659. PubMed ID: 29923306
[TBL] [Abstract][Full Text] [Related]
50. Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis.
Apostolopoulou M; Gordillo R; Koliaki C; Gancheva S; Jelenik T; De Filippo E; Herder C; Markgraf D; Jankowiak F; Esposito I; Schlensak M; Scherer PE; Roden M
Diabetes Care; 2018 Jun; 41(6):1235-1243. PubMed ID: 29602794
[TBL] [Abstract][Full Text] [Related]
51. LPSF/GQ-02 inhibits the development of hepatic steatosis and inflammation in a mouse model of non-alcoholic fatty liver disease (NAFLD).
Soares e Silva AK; de Oliveira Cipriano Torres D; dos Santos Gomes FO; dos Santos Silva B; Lima Ribeiro E; Costa Oliveira A; dos Santos LA; de Lima Mdo C; Pitta Ida R; Peixoto CA
PLoS One; 2015; 10(4):e0123787. PubMed ID: 25875942
[TBL] [Abstract][Full Text] [Related]
52. Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, β-cryptoxanthin.
Ni Y; Nagashimada M; Zhan L; Nagata N; Kobori M; Sugiura M; Ogawa K; Kaneko S; Ota T
Endocrinology; 2015 Mar; 156(3):987-99. PubMed ID: 25562616
[TBL] [Abstract][Full Text] [Related]
53. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
[TBL] [Abstract][Full Text] [Related]
54. The neutral sphingomyelinase-2 is involved in angiogenic signaling triggered by oxidized LDL.
Camaré C; Augé N; Pucelle M; Saint-Lebes B; Grazide MH; Nègre-Salvayre A; Salvayre R
Free Radic Biol Med; 2016 Apr; 93():204-16. PubMed ID: 26855418
[TBL] [Abstract][Full Text] [Related]
55. LPS and palmitate synergistically stimulate sphingosine kinase 1 and increase sphingosine 1 phosphate in RAW264.7 macrophages.
Jin J; Lu Z; Li Y; Ru JH; Lopes-Virella MF; Huang Y
J Leukoc Biol; 2018 Oct; 104(4):843-853. PubMed ID: 29882996
[TBL] [Abstract][Full Text] [Related]
56. Hepatic vagus nerve regulates Kupffer cell activation via α7 nicotinic acetylcholine receptor in nonalcoholic steatohepatitis.
Nishio T; Taura K; Iwaisako K; Koyama Y; Tanabe K; Yamamoto G; Okuda Y; Ikeno Y; Yoshino K; Kasai Y; Okuno M; Seo S; Sakurai T; Asagiri M; Hatano E; Uemoto S
J Gastroenterol; 2017 Aug; 52(8):965-976. PubMed ID: 28044208
[TBL] [Abstract][Full Text] [Related]
57. Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E.
Ni Y; Nagashimada M; Zhuge F; Zhan L; Nagata N; Tsutsui A; Nakanuma Y; Kaneko S; Ota T
Sci Rep; 2015 Nov; 5():17192. PubMed ID: 26603489
[TBL] [Abstract][Full Text] [Related]
58. Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr-/- Mice.
Jeurissen ML; Walenbergh SM; Houben T; Hendrikx T; Li J; Oligschlaeger Y; van Gorp PJ; Gijbels MJ; Bitorina A; Nessel I; Radtke F; Vooijs M; Theys J; Shiri-Sverdlov R
PLoS One; 2016; 11(11):e0167199. PubMed ID: 27898698
[TBL] [Abstract][Full Text] [Related]
59. Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis.
Kasumov T; Li L; Li M; Gulshan K; Kirwan JP; Liu X; Previs S; Willard B; Smith JD; McCullough A
PLoS One; 2015; 10(5):e0126910. PubMed ID: 25993337
[TBL] [Abstract][Full Text] [Related]
60. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
Hur W; Lee JH; Kim SW; Kim JH; Bae SH; Kim M; Hwang D; Kim YS; Park T; Um SJ; Song BJ; Yoon SK
Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
